Article
Senolytic treatment alleviates doxorubicin‐induced chemobrain
15 Jan 2024
Abstract excerpt
Doxorubicin (Dox), a widely used treatment for cancer, can result in chemotherapy-induced cognitive impairments (chemobrain). Chemobrain is associated with inflammation and oxidative stress similar to aging. As such, Dox treatment has also been used as a model of aging. However, it is unclear if Dox induces brain changes similar to that observed during aging since Dox does not readily enter the brain. Rather, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
